Neuroprotection by blood flow stabilization
OwnerStephen L. Macknik, Susana Martinez-Condeinventors
Life of this patent
Estimating the term…
Abstract
A treatment is disclosed for alleviation or prevention of abnormal blood flow to various organs such as the eye, brain, kidneys, heart, feet and other tissues of organs with fine vascular networks that can lead to neurodegeneration as is seen in wet age-related macular degeneration (AMD), epilepsy and diabetes, in which an effective amount of a blood flow regulatory drug is administered to a subject in need of it. Illustrative blood flow regulatory drugs include anticoagulants and vasodilators, and their mixtures.
Claims18
A method for treatment of neurotoxicity or neurodegeneration caused by abnormal blood flow that comprises administration of an effective amount of a blood flow regulatory drug to a subject in need thereof.
A method for treatment of neurotoxicity or neurodegeneration caused by abnormal blood flow in a human patient having wet age-related macular degeneration that comprises administration of an effective amount of a blood flow regulatory drug that is an anticoagulant, a vasodilator, or a mixture thereof to said patient.
A method for treatment of neurotoxicity or neurodegeneration caused by abnormal blood flow in a human patient having epilepsy that comprises administration of an effective amount of a blood flow regulatory drug that is an anticoagulant, a vasodilator, or a mixture thereof to said patient.
A method for treatment of neurotoxicity or neurodegeneration caused by abnormal blood flow in a human patient having diabetes that comprises administration of an effective amount of a blood flow regulatory drug that is an anticoagulant, a vasodilator, or a mixture thereof to said patient.
Dependencies are inferred from the claim text.